1. Home
  2. TSHA vs BRBS Comparison

TSHA vs BRBS Comparison

Compare TSHA & BRBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • BRBS
  • Stock Information
  • Founded
  • TSHA 2019
  • BRBS 1893
  • Country
  • TSHA United States
  • BRBS United States
  • Employees
  • TSHA N/A
  • BRBS N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • BRBS Commercial Banks
  • Sector
  • TSHA Health Care
  • BRBS Finance
  • Exchange
  • TSHA Nasdaq
  • BRBS Nasdaq
  • Market Cap
  • TSHA 262.4M
  • BRBS 290.6M
  • IPO Year
  • TSHA 2020
  • BRBS N/A
  • Fundamental
  • Price
  • TSHA $1.24
  • BRBS $3.13
  • Analyst Decision
  • TSHA Strong Buy
  • BRBS
  • Analyst Count
  • TSHA 8
  • BRBS 0
  • Target Price
  • TSHA $6.63
  • BRBS N/A
  • AVG Volume (30 Days)
  • TSHA 2.4M
  • BRBS 178.0K
  • Earning Date
  • TSHA 05-13-2025
  • BRBS 04-29-2025
  • Dividend Yield
  • TSHA N/A
  • BRBS N/A
  • EPS Growth
  • TSHA N/A
  • BRBS N/A
  • EPS
  • TSHA N/A
  • BRBS N/A
  • Revenue
  • TSHA $8,333,000.00
  • BRBS $97,334,000.00
  • Revenue This Year
  • TSHA N/A
  • BRBS N/A
  • Revenue Next Year
  • TSHA N/A
  • BRBS N/A
  • P/E Ratio
  • TSHA N/A
  • BRBS N/A
  • Revenue Growth
  • TSHA N/A
  • BRBS N/A
  • 52 Week Low
  • TSHA $1.05
  • BRBS $2.45
  • 52 Week High
  • TSHA $4.32
  • BRBS $3.83
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 40.35
  • BRBS 44.49
  • Support Level
  • TSHA $1.05
  • BRBS $3.06
  • Resistance Level
  • TSHA $1.36
  • BRBS $3.19
  • Average True Range (ATR)
  • TSHA 0.17
  • BRBS 0.13
  • MACD
  • TSHA -0.01
  • BRBS 0.00
  • Stochastic Oscillator
  • TSHA 25.68
  • BRBS 48.28

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About BRBS Blue Ridge Bankshares Inc.

Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.

Share on Social Networks: